Deliver Your News to the World

Philips again recognized as a Clarivate Top 100 Global Innovator

For the eighth consecutive year, Philips wins a Top-100 place for the volume, influence, success and globalization of its innovation


Amsterdam, the Netherlands – WEBWIRE
Philips Azurion image-guided therapy platform
Philips Azurion image-guided therapy platform

I am very pleased that we have again been named as a Clarivate Top 100 Global Innovator, for the 8th consecutive year. This is another much-valued recognition of our ability to create breakthrough innovations that improve people’s health and well-being.” Frans van Houten, CEO of Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has once again been recognized as a Clarivate Top 100 Global Innovator™ in Clarivate Analytics’ 2021 list, which identifies the world’s most innovative companies by measuring the ideation culture that produces patents [1]. Philips has now successively won a place on this prestigious list for eight consecutive years.

“I am very pleased that we have again been named as a Clarivate Top 100 Global Innovator, for the 8th consecutive year. This is another much-valued recognition of our ability to create breakthrough innovations that improve people’s health and well-being.” Frans van Houten, CEO of Royal Philips

“Our global R&D program and strong intellectual property portfolio continue to fuel our ability to truly impact global health challenges through innovation,” said Frans van Houten, CEO of Royal Philips. “I am very pleased that we have again been named as a Clarivate Top 100 Global Innovator, for the 8th consecutive year. This is another much-valued recognition of our ability to create breakthrough innovations that improve people’s health and well-being.”

Philips’ EUR 1.9 billion R&D program has resulted in the introduction of many successful recent innovations, including:

  • major extensions to Philips’ industry-leading Azurion image-guided therapy platform, comprising a new range of configurations to innovate procedures in a broad range of therapeutic areas, and further integration between imaging and diagnostic devices
  • a vendor-neutral, multimodality Radiology Operations Command Center to enable real-time, remote collaboration between technologists, radiologists, and imaging teams across multiple sites
  • several new monitoring solutions for Intensive Care Units (ICUs), general wards and patients’ homes that feature remote monitoring capabilities and advanced analytics, including the IntelliVue Patient Monitors MX750/MX850 for the ICU, and Biosensor BX100 for detecting early patient deterioration on general wards
  • the Philips Shaver S7000, an AI-powered shaver with SkinIQ technology senses, guides and adapts to men’s skin and facial hair to improve shaving efficiency and skin comfort. When connected to the Philips GroomTribe app, it provides a personal shave plan based on individual shaving technique.


The ‘Clarivate Top 100 Global Innovators 2021’ come from three continents and 14 countries/regions. The report and a full list of the Top 100 organizations can be found here.

[1] To compile its ‘Clarivate Top 100 Global Innovators’ list, Clarivate tracks innovation based on four indicators: 1. Volume: A volume threshold of 100 granted inventions in the past five years and more than 500 filed in total over any time period. 2. Influence: Patented ideas’ level of influence based on the number of external citations an organization’s inventions has received in the past five years -- references made to an organization’s patents during the application and examination process from patents later registered by someone else. 3. Success: The level of success in getting patent protection applications issued by the patent offices of the world in the same five-year window. 4. Globalization: The level of investment in an organization’s patent applications, to determine the footprint of commercialization and patent application investment, measured by filing activity level in Europe, Japan, Mainland China and the United States, jurisdictions that speak to significant cost.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.


( Press Release Image: https://photos.webwire.com/prmedia/5/270878/270878-1.jpg )


WebWireID270878





This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.